Seeking Alpha

Over the last several decades, the animal health market has outgrown the U.S. economy and been more resistant to economic cycles. Moreover, the vet market is an attractive vehicle for investors to participate in the growth of the broader healthcare industry without reimbursement risk. U.S. consumers will spend an estimated $55.53 billion on pets this year - a number that has been growing at a pace of more than 5% over the past decade. Therapeutics constitutes a small portion of this market but is poised to expand as pet care becomes more complex and companies roll out new products for unmet needs. In this article, we decided to evaluate Aratana Therapeutics (PETX), a small-cap biopharmaceutical company...

Only subscribers can access this article, which is part of the PRO research library covering 3,792 different stocks.
Growing numbers of fund managers and other investment professionals subscribe to Seeking Alpha PRO for equity research that is unavailable elsewhere, so they can: